Načítá se...
Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
Immunotherapies are becoming increasingly important in the treatment armamentarium of a variety of malignancies. Immune checkpoint inhibitors are the most representative drugs receiving regulatory approval over the past few years. In a recent study published in Clinical Cancer Research, we demonstra...
Uloženo v:
| Vydáno v: | Integr Cancer Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247554/ https://ncbi.nlm.nih.gov/pubmed/30229677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735418801524 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|